Stacy P. Ardoin, MD :: Nationwide Children’s Hospital, Columbus, Ohio

Stacy P. Ardoin, MD

Stacy P. Ardoin, MD Best Doctors 2011-2012

Contact Information

Rheumatology
700 Children's Dr
Columbus, OH 43205 [ map ]
PH: (614) 722-5525
FX: (614) 722-3194

Location Information for Patients

Main Campus

Biography

Gender:

  • Female

Languages Spoken:

  • English

Education and Training

Medical School

  • Ohio State University
    Date Completed: 06/13/1997

Residency

  • Nationwide Children's Hospital
    Date Completed: 06/30/2001

Residency

  • OSUWMC Department of Internal Medicine
    Date Completed: 06/30/2002

Fellowship

  • Duke University Medical Center - Durham
    Date Completed: 06/30/2006

Department:

  • Pediatrics

Section:

  • Rheumatology

Specialty:

  • Pediatric Rheumatology
  • Rheumatology

Date of Appointment at Nationwide Children’s Hospital:

  • 03/02/2009

Publications

  • 2016. Usability and workflow evaluation of “RhEumAtic disease activity” (READY): A mobile application for rheumatology patients and providers.  Applied Clinical Informatics. Vol. 7, no. 4. (November 2).
  • 2016. Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study.  Scandinavian Journal of Rheumatology. Vol. 45, no. 4. (July 3).
  • 2016. Development of a Novel Renal Activity Index of Lupus Nephritis in Children and Young Adults.  Arthritis Care and Research. Vol. 68, no. 7. (July 1).
  • 2016. Transitioning Wisely: Improving the Connection from Pediatric to Adult Health Care.  Arthritis and Rheumatology. Vol. 68, no. 4. (April 1).
  • 2016. Initial Benchmarking of the Quality of Medical Care in Childhood-Onset Systemic Lupus Erythematosus.  Arthritis Care and Research. Vol. 68, no. 2. (February 1).
  • 2016. Two cases of thrombosis in patients with antiphospholipid antibodies during treatment of immune thrombocytopenia with romiplostim, a thrombopoietin receptor agonist.  Seminars in Arthritis and Rheumatism. Vol. 45, no. 4. (February 1).
  • 2016. Validation of the Lupus Nephritis Clinical Indices in Childhood-Onset Systemic Lupus Erythematosus.  Arthritis Care and Research. Vol. 68, no. 2. (February 1).
  • 2016. Relationship of cell-free urine MicroRNA with lupus nephritis in children.  Pediatric Rheumatology. Vol. 14, no. 1. (January 14).
  • 2015. US Adult Rheumatologists Perspective on the Transition Process for Young Adults with Rheumatic Conditions.
  • 2015. Urinary Cell-Free Microrna's As Biomarkers of Lupus Nephritis in Children.
  • 2015. Quantitative evaluation of a pediatric rheumatology transition program.  PEDIATRIC RHEUMATOLOGY. Vol. 13, no. May 24.
  • 2015. Factors associated with thrombosis in pediatric patients with systemic lupus erythematosus.  Lupus. Vol. 25, no. 7. (January 1).
  • 2014. Accuracy of Laboratory Measures and Clinical Renal Activity Indices for Reflecting Biopsy-Proven Lupus Nephritis (LN) Activity.
  • 2014. Juvenile Rheumatoid Arthritis and Future Risk for Cardiovascular Disease; A Multicenter Population-Based Study.
  • 2014. Development of an Index to Non-Invasively Quantify Lupus Nephritis Chronicity in Children.
  • 2014. Analysis of Risk Factors for Thrombosis in Pediatric Patients with Systemic Lupus Erythematosus.  ARTHRITIS & RHEUMATOLOGY. Vol. 66, no. October 1.
  • 2014. Increasing Rates of Remission in Juvenile Idiopathic Arthritis through a Quality Improvement Learning Network - the Pediatric Rheumatology Care and Outcomes Improvement Network.
  • 2014. Assessment of Transition Readiness in Adolescents and Young Adults with Rheumatic and Other Chronic Health Conditions.
  • 2014. A Renal Activity Index May Predict Histological Activity in Lupus Nephritis in Children.
  • 2014. Cardiac Magnetic Resonance Imaging in Systemic Lupus Erythematosus.  ARTHRITIS & RHEUMATOLOGY. Vol. 66, no. October 1.
  • 2014. Initial Benchmarking of the Quality of Medical Care of Childhood-Onset Systemic Lupus Erythematosus.
  • 2014. Vitamin D status is a determinant of atorvastatin effect on carotid intima medial thickening progression rate in children with lupus: An Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) substudy.  Lupus Science and Medicine. Vol. 1, no. 1. (June 1).
  • 2014. Choosing Wisely: The American College of Rheumatology's Top 5 for Pediatric Rheumatology.  ARTHRITIS CARE & RESEARCH. Vol. 66, no. 5. (May 1).
  • 2014. Transitioning Youth with Rheumatic Conditions: Perspectives of Pediatric Rheumatology Providers in the United States and Canada.  JOURNAL OF RHEUMATOLOGY. Vol. 41, no. 4. (April 1).
  • 2014. A Population Management Tool for Proactive Care of Juvenile Idiopathic Arthritis in the Pediatric Rheumatology Care and Outcomes Improvement Network.
  • 2014. Pediatric Rheumatology Care and Outcomes Improvement Network Demonstrates Performance Improvement on Juvenile Idiopathic Arthritis Quality Measures.
  • Ardoin,Stacy,P; Schanberg,Laura,Eve; Sandborg,Christy,I; Barnhart,Huiman,X; Evans,Greg,W; Yow,Eric; Mieszkalski,Kelly,L; Ilowite,Norman,T; Eberhard,Anne; Imundo,Lisa,F; Kimura,Yuki; Levy,Deborah; von Scheven,Emily; Silverman,Earl; Bowyer,Suzanne,L; Punaro,L; Singer,Nora,G; Sherry,David,D; McCurdy,Deborah,K; Klein-Gitelman,Marissa; Wallace,Carol; Silver,Richard,M; Wagner-Weiner,Linda; Higgins,Gloria,C; Brunner,Hermine,I; Jung,Lawrence; Soep,Jennifer,B; Reed,Ann,M; Thompson,Susan,D. 2014. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.  ANNALS OF THE RHEUMATIC DISEASES. Vol. 73, no. 3. (March): 557-566.
  • 2014. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.  ANNALS OF THE RHEUMATIC DISEASES. Vol. 73, no. 3. (March 1).
  • 2014. Clinical Inactive Disease in the Pediatric Rheumatology Care and Outcomes Improvement Network Cohort: Which Components of Clinical Inactive Disease Do Patients Not Achieve?.  ARTHRITIS & RHEUMATOLOGY. Vol. 66, no. March 1.
  • Bingham,Catherine,A; Ardoin,Stacy,P; Vora,Sheetal,S; Darbie,Lynn,M; Lovell,Daniel,J; Weiss,Jennifer,E; Laxer,Ronald,M; Olson,Judyann,C; Passo,Murray,H; Gottlieb,Beth,S; Stock,Jason,A; Dewitt,Esi,Morganv. 2014. A1: clinical inactive disease in the pediatric rheumatology care and outcomes improvement network cohort: which components of clinical inactive disease do patients not achieve?.  Arthritis & rheumatology (Hoboken, N.J.). Vol. 66, no. March: S1-2.
  • 2014. Consensus Treatment Plans for Induction Therapy in Childhood Proliferative Lupus Nephritis-Status of Use in Daily Clinical Care.
  • 2014. Pre-visit Planning and Quality Improvement in Juvenile Idiopathic Arthritis.
  • Ardoin,Stacy,P; Schanberg,Laura,Eve; Sandborg,Christy,I; Barnhart,Huiman,X; Evans,Greg,W; Yow,Eric; Mieszkalski,Kelly,L; Ilowite,Norman,T; Eberhard,Anne; Imundo,Lisa,F; Kimura,Yuki; Levy,Deborah; von Scheven,Emily; Silverman,Earl; Bowyer,Suzanne,L; Punaro,L; Singer,Nora,G; Sherry,David,D; McCurdy,Deborah,K; Klein-Gitelman,Marissa; Wallace,Carol; Silver,Richard,M; Wagner-Weiner,Linda; Higgins,Gloria,C; Brunner,Hermine,I; Jung,Lawrence; Soep,Jennifer,B; Reed,Ann,M; Thompson,Susan,D. 2014. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.  ANNALS OF THE RHEUMATIC DISEASES. Vol. 73, no. 3. (March 1): 557-566-557-566.
  • 2014. Rheumatoid arthritis: An autoimmune disease with female preponderance and cardiovascular risk equivalent to diabetes mellitus: Role of cardiovascular magnetic resonance.  Inflammation and Allergy - Drug Targets. Vol. 13, no. 2. (January 1).
  • Mavrogeni S, Dimitroulas T, Buccareli-Ducci C, Ardoin S, Sfikakis PP, Kolovou G, Kitas GD. 2014. Rheumatoid Arthritis: an autoimmune disease with female preponderance and cardiovascular risk equivalent to Diabetes Mellitus: Role of Cardiovascular Magnetic Resonance.  Inflamm Allergy Drug Targets. Vol. 13, no. January: 1871-5281.
  • 2013. Pediatric Rheumatology Care and Outcomes Improvement Network Demonstrates Performance Improvement On Juvenile Idiopathic Arthritis Quality Measures.
  • 2013. Reply to the letter to the editor.  Toxicology in vitro : an international journal published in association with BIBRA. Vol. 27, no. 2. (March 1).
  • Ardoin SP; Schanberg LE; Sandborg CI; et al. 2013. Secondary Analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.  Ann Rheum Dis.. Vol. 0, no. February: 1-10.
  • 2013. Association of systemic lupus erythematosus with angiographically defined coronary artery disease: A retrospective cohort study.  Arthritis Care and Research. Vol. 65, no. 2. (February 1).
  • 2013. Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders.  ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. Vol. 110, no. 1. (January 1).
  • Cho CB, Stutes SA, Altrich ML, Ardoin SP, Phillips G, Ogbogu PU. 2013. Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders.  Ann Allergy Asthma Immunol. Vol. 110(1), no. January: 29-33.
  • Mascarenhas S, Avalos B, Ardoin SP. 2012. An update on stem cell transplatation in autoimmune rheumatologic disorders.  Curr Allergy Asthma Rep. Vol. 12(6), no. December: 530-40.
  • 2012. An update on stem cell transplantation in autoimmune rheumatologic disorders.  Current Allergy and Asthma Reports. Vol. 12, no. 6. (December 1).
  • Mascarenhas S, Avalos B, Ardoin SP. 2012. An update on stem cell transplatation in autoimmune rheumatologic disorders.  Curr Allergy Asthma Rep. Vol. 12(6), no. December 1: 530-40-530-40.
  • 2012. Improving Delivery of Care for JIA Across a Multi-Center Network Using a Shared Data Registry and Quality Improvement Science: The Pediatric Rheumatology Care and Outcomes Improvement Network.
  • 2012. Do Serum Hepcidin 25 Levels Predict SLE Renal or Non-Renal Flares?. In Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP)
  • 2012. Uveitis Surveillance Through Lean-Six Sigma for Quality Assurance in Juvenile Idiopathic Arthritis. In Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP)
  • 2012. Paediatric rheumatic disease: Lessons from SLE: Children are not little adults.  Nature Reviews Rheumatology. Vol. 8, no. 8. (August 1).
  • 2012. Reply.  Arthritis and Rheumatism. Vol. 64, no. 8. (August 1).
  • Ardoin,Stacy,P; Evans,Gregory; Sandborg,Christy; Barnhart,Huiman,X; Schanberg,Laura,E. 2012. A clinically relevant benefit of statins in young patients with systemic lupus erythematosus cannot be excluded: comment on the article by Schanberg et al Reply.  ARTHRITIS AND RHEUMATISM. Vol. 64, no. 8. (August): 2805-2806.
  • Kaul MS, Rao SV, Shaw LK, Honeycutt E, Ardoin SP, Clair EW. 2012. Association of systemic lupus erythematosus with angiographically-defined coronary artery disease: A retrospective cohort study.  Arthritis Care Res (Hoboken). Vol. 0, no. June: e0.
  • Ardoin SP, Schanberg LE. 2012. Paediatric rheumatic disease: Lessons from SLE: children are not little adults.  Nat Rev Rheumatology. Vol. 0, no. June: e0.
  • Ardoin SP, Barnhart HX, Evans G, Sandborg C, Schanberg LE. 2012. Reply to Letter to the Editor.  Arthritis Rheumatology. Vol. 0, no. May: e0.
  • 2012. Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus.  Arthritis Care and Research. Vol. 64, no. 3. (March 1).
  • Mina R, von Scheven E, Ardoin SP, Eberhard BA, Punaro M, Ilowite N, Hsu J, Klein-Gitelman M, Moorthy LN, Muscal E, Radhakrishna SM, Wagner-Weiner L, Adams M, Blier P, Buckley L, Chalom E, Chedeville G, Eichenfield A, Fish N, Henrickson M, Hersh AO, Hollister R, Jones O, Jung L, Levy D, Lopez-Benitez J, McCurdy D, Miettunen PM, Quintero-del Rio AI, Rothman D, Rullo O, Ruth N, Schanberg LE, Silverman E, Singer NG, Soep J, Syed R, Vogler LB, Yalcindag A, Yidirim-Toruner C, Wallace CA, Brunner HI; Carra SLE Subcommittee. 2012. Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus.  Arthritis Care Res (Hoboken). Vol. 64(3), no. March: 375-83.
  • 2012. Auto-antibodies in Chronic Idiopathic Urticaria (CIU) and Non-urticarial Systemic Autoimmune Disorders.  JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Vol. 129, no. 2. (February 1).
  • 2012. Use of atorvastatin in systemic lupus erythematosus in children and adolescents.  ARTHRITIS AND RHEUMATISM. Vol. 64, no. 1. (January 1).
  • Schanberg,L,E; Sandborg,C; Barnhart,H,X; Ardoin,S,P; Yow,E; Evans,G,W; Mieszkalski,K,L; Ilowite,N,T; Eberhard,A; Imundo,L,F; Kimura,Y; von Scheven,E; Silverman,E; Bowyer,S,L; Punaro,M; Singer,N,G; Sherry,D,D; McCurdy,D; Klein-Gitelman,M; Wallace,C; Silver,R; Wagner-Weiner,L; Higgins,G,C; Brunner,H,I; JUNG,L; Soep,J,B; Reed,A,M; Provenzale,J; Thompson,S,D. 2012. Use of atorvastatin in systemic lupus erythematosus in children and adolescents.  ARTHRITIS AND RHEUMATISM. Vol. 64, no. 1. (January): 285-296.
  • Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, Mieszkalski KL, Ilowite NT, Eberhard A, Imundo LF, Kimura Y, von Scheven E, Silverman E, Bowyer SL, Punaro M, Singer NG, Sherry DD, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins GC, Brunner HI, Jung L, Soep JB, Reed AM, Provenzale J, Thompson SD. 2012. Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators. Use of atorvastatin in systemic lupus erythematosus in children and adolescents.  Arthritis Rheumatology. Vol. 64(1), no. January: 285-96.
  • Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, Mieszkalski KL, Ilowite NT, Eberhard A, Imundo LF, Kimura Y, von Scheven E, Silverman E, Bowyer SL, Punaro M, Singer NG, Sherry DD, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins GC, Brunner HI, Jung L, Soep JB, Reed AM, Provenzale J, Thompson SD. 2012. Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators. Use of atorvastatin in systemic lupus erythematosus in children and adolescents.  Arthritis Rheumatology. Vol. 64(1), no. January 1: 285-96-285-96.
  • Schanberg,L,E; Sandborg,C; Barnhart,H,X; Ardoin,S,P; Yow,E; Evans,G,W; Mieszkalski,K,L; Ilowite,N,T; Eberhard,A; Imundo,L,F; Kimura,Y; von Scheven,E; Silverman,E; Bowyer,S,L; Punaro,M; Singer,N,G; Sherry,D,D; McCurdy,D; Klein-Gitelman,M; Wallace,C; Silver,R; Wagner-Weiner,L; Higgins,G,C; Brunner,H,I; JUNG,L; Soep,J,B; Reed,A,M; Provenzale,J; Thompson,S,D. 2012. Use of atorvastatin in systemic lupus erythematosus in children and adolescents.  ARTHRITIS AND RHEUMATISM. Vol. 64, no. 1. (January 1): 285-296-285-296.
  • Schanberg,L,E; Sandborg,C; Barnhart,H,X; Ardoin,S,P; Yow,E; Evans,G,W; Mieszkalski,K,L; Ilowite,N,T; Eberhard,A; Imundo,L,F; Kimura,Y; von Scheven,E; Silverman,E; Bowyer,S,L; Punaro,M; Singer,N,G; Sherry,D,D; McCurdy,D; Klein-Gitelman,M; Wallace,C; Silver,R; Wagner-Weiner,L; Higgins,G,C; Brunner,H,I; JUNG,L; Soep,J,B; Reed,A,M; Provenzale,J; Thompson,S,D. 2012. Use of atorvastatin in systemic lupus erythematosus in children and adolescents.  ARTHRITIS AND RHEUMATISM. Vol. 64, no. 1. (January): 285-296.
  • 2011. Etanercept treatment to enable successful hepatitis C virus clearance in a patient with rheumatoid arthritis.  Gastroenterology and Hepatology. Vol. 7, no. 11. (November 1).
  • Jazwinski AB, Jezsik J, Ardoin SP, McCallum RM, Tillmann HL. 2011. Etanercept treatment to enable successful hepatitis C virus clearance in a patient with rheumatoid arthritis.  Gastroenterol Hepatol (NY). Vol. 7(11), no. November: 772-4.
  • 2011. A Secondary Analysis of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Study Shows That Atorvastatin Therapy Reduces Progression of Carotid Intima Medial Thickening in Pubertal SLE Patients with Higher C Reactive Protein.
  • 2011. Developing Consensus Treatment Plans for Proliferative Nephritis in Juvenile Systemic Lupus Erythematosus: Maintenance Therapy.
  • 2011. CD146+ Endothelial Progenitor Cell Number Increases Following 36 Months of Atorvastatin Therapy in Children and Adolescents with SLE: The Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Cohort. In 75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals
  • 2011. An Approach to Validating Criteria for Proteinuric Flare in Systemic Lupus Erythematosus Glomerulonephritis.  ARTHRITIS AND RHEUMATISM. Vol. 63, no. 7. (July 1).
  • Ardoin SP, Birmingham DJ, Hebert PL Yu C-Y, Rovin BH, Hebert LA. 2011. An approach to vailidate criteria for proteinuric flare in systemic lupus erythematosus glomerulonephritis.  Arthritis Rheum. Vol. 63, no. 7. (January): 2031-2037.
  • Ardoin SP, Birmingham DJ, Hebert PL Yu C-Y, Rovin BH, Hebert LA. 2011. An approach to vailidate criteria for proteinuric flare in systemic lupus erythematosus glomerulonephritis.  Arthritis Rheum. Vol. 63, no. 7. (January 1): 2031-2037-2031-2037.
  • Ardoin SP, Schanberg LE. 2011. Systemic Lupus Erythematosus. In Nelson's Textbook of Pediatric Rheumatology, 19th ED. Edited by Robert Kliegman. Philadelphia: Elseiver/Saunders.
  • Ardoin SP, Fels E. 2011. Vasculitis. In Nelsons Textbook of Pediatric Rheumatology, 19th ED. Edited by Robert Kliegman. Philadelphia: Elseiver/Saunders.
  • 2010. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis [5].  New England Journal of Medicine. Vol. 363, no. 21. (November 18).
  • Hebert LA; Ardoin S; Shim RL. 2010. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.  The New England Journal Of Medicine. Vol. 363, no. 21. (November): e2072.
  • Ardoin SP; Schanberg LE; Sandborg C; Yow E; Barnhart HX; Mieszkalski K; Ilowite NT; von Scheven E; Eberhard A; Levy DM; Kimura Y; Silverman E; Bowyer SL; Punaro L; Singer NG; Sherry DD; McCurdy D; Klein-Gitelman M; Wallace C; Silver R; Wagner-Weiner L; Higgins GC; Brunner HI; Jung LK; Imundo L; Soep JB; Reed AM. 2010. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort.  Lupus. Vol. 19, no. 11. (October 1): 1315-1315.
  • Ardoin SP; Schanberg LE; Sandborg C; Yow E; Barnhart HX; Mieszkalski K; Ilowite NT; von Scheven E; Eberhard A; Levy DM; Kimura Y; Silverman E; Bowyer SL; Punaro L; Singer NG; Sherry DD; McCurdy D; Klein-Gitelman M; Wallace C; Silver R; Wagner-Weiner L; Higgins GC; Brunner HI; Jung LK; Imundo L; Soep JB; Reed AM. 2010. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort.  Lupus. Vol. 19, no. 11. (October): e1315.
  • Ardoin SP; Schanberg LE; Sandborg C; Yow E; Barnhart HX; Mieszkalski K; Ilowite NT; von Scheven E; Eberhard A; Levy DM; Kimura Y; Silverman E; Bowyer SL; Punaro L; Singer NG; Sherry DD; McCurdy D; Klein-Gitelman M; Wallace C; Silver R; Wagner-Weiner L; Higgins GC; Brunner HI; Jung LK; Imundo L; Soep JB; Reed AM. 2010. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort.  Lupus. Vol. 19, no. 11. (October 1): 1315-1315.
  • Ardoin SP; Schanberg LE; Sandborg C; Yow E; Barnhart HX; Mieszkalski K; Ilowite NT; von Scheven E; Eberhard A; Levy DM; Kimura Y; Silverman E; Bowyer SL; Punaro L; Singer NG; Sherry DD; McCurdy D; Klein-Gitelman M; Wallace C; Silver R; Wagner-Weiner L; Higgins GC; Brunner HI; Jung LK; Imundo L; Soep JB; Reed AM. 2010. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort.  Lupus. Vol. 19, no. 11. (October): e1315.
  • 2010. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort.  LUPUS. Vol. 19, no. 11. (October 1).
  • Ardoin,S,P; Schanberg,L,E; Sandborg,C; Yow,E; Barnhart,H,X; Mieszkalski,K,L; Ilowite,N,T; von Scheven,E; Eberhard,A; Levy,D,M; Kimura,Y; Silverman,E; Bowyer,S,L; Punaro,L; Singer,N,G; Sherry,D,D; McCurdy,D; Klein-Gitelman,M; Wallace,C; Silver,R; Wagner-Weiner,L; Higgins,G,C; Brunner,H,I; Jung,L,K; Imundo,L; Soep,J,B; Reed,A,M. 2010. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort.  LUPUS. Vol. 19, no. 11. (October): 1315-1325.
  • 2010. Postmenopausal hormone therapy: an Endocrine Society scientific statement.  The Journal of clinical endocrinology and metabolism. Vol. 95, no. 7 Suppl 1. (July 1).
  • Santen,Richard,J; Allred,D,Craig; Ardoin,Stacy,P; et al. 2010. Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement.  JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. Vol. 95, no. 7. (July 1): S1-S66-S1-S66.
  • 2010. Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement.  JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. Vol. 95, no. 7. (July 1).
  • Richard J. Santen, D. Craig Allred, Stacy P. Ardoin,et al. 2010. Executive Summary: Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement.  J Clin Endocrinol Metab. Vol. 95(Suppl 1), no. July: S1-S66.
  • Richard J. Santen, D. Craig Allred, Stacy P. Ardoin,et al. 2010. Executive Summary: Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement.  J Clin Endocrinol Metab. Vol. 95(Suppl 1), no. July 1: S1-S66-S1-S66.
  • Santen,Richard,J; Allred,D,Craig; Ardoin,Stacy,P; Archer,David,F; Boyd,Norman; Braunstein,Glenn,D; Burger,Henry,G; Colditz,Graham,A; Davis,Susan,R; Gambacciani,Marco; Gower,Barbara,A; Henderson,Victor,W; Jarjour,Wael,N; Karas,Richard,H; Kleerekoper,Michael; Lobo,Roger,A; Manson,JoAnn,E; Marsden,Jo; Martin,Kathryn,A; Martin,Lisa; Pinkerton,JoAnn,V; Rubinow,David,R; Teede,Helena; Thiboutot,Diane,M; Utian,Wulf,H. 2010. Postmenopausal hormone therapy: an Endocrine Society scientific statement.  journal of clinical endocrinology & metabolism. Vol. 95, no. 7. (July 1): s1-s66-s1-s66.
  • Santen,Richard,J; Allred,D,Craig; Ardoin,Stacy,P; et al. 2010. Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement.  JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. Vol. 95, no. 7. (July): S1-S66.
  • 2009. Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood.  Arthritis and Rheumatism. Vol. 60, no. 11. (November 1).
  • Schanberg LE; Sandborg C; Barnhart HX; Ardoin SP; Yow E; Evans GW; Mieszkalski KL; Ilowite NT; Eberhard A; Levy DM; Kimura Y; von Scheven E; Silverman E; Bowyer SL; Punaro L; Singer NG; Sherry DD; McCurdy D; Klein-Gitelman M; Wallace C; Silver R; Wagner-Weiner L; Higgins GC; Brunner HI; Jung L; Soep JB; Reed A. 2009. Premature Atherosclerosis in Pediatric Systemic Lupus Erythematosus: Risk Factors for Increased Carotid Intima-Media Thickness in the Atherosclerosis Prevention in Pediatric Lupus Erythematosus Cohort.  Arthritis And Rheumatism. Vol. 60, no. 5. (May 1): 1496-1496.
  • Schanberg,Laura,E; Sandborg,Christy; Barnhart,Huiman,X; Ardoin,Stacy,P; Yow,Eric; Evans,Gregory,W; Mieszkalski,Kelly,L; Ilowite,Norman,T; Eberhard,Anne; Levy,Deborah,M; Kimura,Yukiko; von Scheven,Emily; Silverman,Earl; Bowyer,Suzanne,L; Punaro,Lynn; Singer,Nora,G; Sherry,David,D; McCurdy,Deborah; Klein-Gitelman,Marissa; Wallace,Carol; Silver,Richard; Wagner-Weiner,Linda; Higgins,Gloria,C; Brunner,Hermine,I; Jung,Lawrence; Soep,Jennifer,B; Reed,Ann. 2009. Premature Atherosclerosis in Pediatric Systemic Lupus Erythematosus.  ARTHRITIS AND RHEUMATISM. Vol. 60, no. 5. (May): 1496-1507.
  • 2009. Premature Atherosclerosis in Pediatric Systemic Lupus Erythematosus.  ARTHRITIS AND RHEUMATISM. Vol. 60, no. 5. (May 1).
  • Schanberg,Laura,E; Sandborg,Christy; Barnhart,Huiman,X; Ardoin,Stacy,P; Yow,Eric; Evans,Gregory,W; Mieszkalski,Kelly,L; Ilowite,Norman,T; Eberhard,Anne; Levy,Deborah,M; Kimura,Yukiko; von Scheven,Emily; Silverman,Earl; Bowyer,Suzanne,L; Punaro,Lynn; Singer,Nora,G; Sherry,David,D; McCurdy,Deborah; Klein-Gitelman,Marissa; Wallace,Carol; Silver,Richard; Wagner-Weiner,Linda; Higgins,Gloria,C; Brunner,Hermine,I; Jung,Lawrence; Soep,Jennifer,B; Reed,Ann. 2009. Premature Atherosclerosis in Pediatric Systemic Lupus Erythematosus.  ARTHRITIS AND RHEUMATISM. Vol. 60, no. 5. (May 1): 1496-1507-1496-1507.
  • Schanberg LE; Sandborg C; Barnhart HX; Ardoin SP; Yow E; Evans GW; Mieszkalski KL; Ilowite NT; Eberhard A; Levy DM; Kimura Y; von Scheven E; Silverman E; Bowyer SL; Punaro L; Singer NG; Sherry DD; McCurdy D; Klein-Gitelman M; Wallace C; Silver R; Wagner-Weiner L; Higgins GC; Brunner HI; Jung L; Soep JB; Reed A. 2009. Premature Atherosclerosis in Pediatric Systemic Lupus Erythematosus: Risk Factors for Increased Carotid Intima-Media Thickness in the Atherosclerosis Prevention in Pediatric Lupus Erythematosus Cohort.  Arthritis And Rheumatism. Vol. 60, no. 5. (May): e1496.
  • 2009. Neurocognitive impairment in children and adolescents with systemic lupus erythematosus.  Nature Clinical Practice Rheumatology. Vol. 5, no. 2. (February 16).
  • Levy DM; Ardoin SP; Schanberg LE. 2009. Neurocognitive Impairment in Children and Adolescents with Systemic Lupus Erythematosus.  Nature Clinical Practice. Rheumatology. Vol. 5, no. 2. (February): e106.
  • 2008. Developments in the scientific understanding of lupus.  Arthritis Research and Therapy. Vol. 10, no. 5. (October 10).
  • 2008. Retrospective analysis of neurocognitive testing in children and adolescents with SLE.
  • 2008. Therapy Insight: Cardiovascular disease in pediatric systemic lupus erythematosus.  Nature Clinical Practice Rheumatology. Vol. 4, no. 5. (May 1).
  • Sandborg C; Ardoin SP; Schanberg L. 2008. Therapy Insight: Cardiovascular Disease in Pediatric Systemic Lupus Erythematosus.  Nature Clinical Practice. Rheumatology. Vol. 4, no. 5. (May): e258.
  • 2008. The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation.  Modern Rheumatology. Vol. 18, no. 4. (April 17).
  • 2008. Clinical trials in pediatric rheumatology: Comment on the editorial by Lehman.  Arthritis and Rheumatism. Vol. 58, no. 4. (April 1).
  • DeWitt EM; Ardoin SP; Rabinovich CE; Schanberg LE. 2008. Clinical Trials in Pediatric Rheumatology: Comment on the Editorial by Lehman.  Arthritis And Rheumatism. Vol. 58, no. 4. (April): e1202.
  • Ardoin SP, Pisetsky DP. 2008. Developments in the Scientific Understanding of Lupus.  Arthritis Res Ther. Vol. 10, no. 5. (January): e218.
  • Ardoin SP; Pisetsky DS. 2008. The Role of Cell Death in the Pathogenesis of Autoimmune Disease: HMGB1 and Microparticles as Intercellular Mediators of Inflammation.  Modern Rheumatology / The Japan Rheumatism Association. Vol. 18, no. 4. (January): e319.
  • 2007. Predictors of increased carotid intima media thickness (CIMT) in the atherosclerosis prevention in pediatric lupus erythernatosus (APPLE) cohort.
  • 2007. Infliximab to Treat Chronic Noninfectious Uveitis in Children: Retrospective Case Series with Long-term Follow-up.  American Journal of Ophthalmology. Vol. 144, no. 6. (December 1).
  • Ardoin SP; Kredich D; Rabinovich E; Schanberg LE; Jaffe GJ. 2007. Infliximab to Treat Chronic Noninfectious Uveitis in Children: Retrospective Case Series with Long-Term Follow-Up.  American Journal Of Ophthalmology. Vol. 144, no. 6. (December): e844.
  • 2007. Management of dyslipidemia in children and adolescents with systemic lupus erythematosus.  Lupus. Vol. 16, no. 8. (September 10).
  • 2007. The role of microparticles in inflammation and thrombosis.  Scandinavian Journal of Immunology. Vol. 66, no. 2-3. (August 1).
  • Ardoin SP; Shanahan JC; Pisetsky DS. 2007. The Role of Microparticles in Inflammation and Thrombosis.  Scandinavian Journal Of Immunology. Vol. 66, no. 2-3. (August): e159.
  • Ardoin SP; Sandborg C; Schanberg LE. 2007. Management of Dyslipidemia in Children and Adolescents with Systemic Lupus Erythematosus.  Lupus. Vol. 16, no. 8. (January): e618.
  • 2006. Update on nonsteriodal anti-inflammatory drugs.  Current Opinion in Rheumatology. Vol. 18, no. 3. (May 1).
  • Ardoin SP, Sundy JS. 2006. Update on nonsteriodal anti-inflammatory drugs.  CURRENT OPINION IN RHEUMATOLOGY. Vol. 18, no. 3. (May): 221-226.
  • Ardoin SP; Schanberg LE. 2005. The Management of Pediatric Systemic Lupus Erythematosus.  Nature Clinical Practice. Rheumatology. Vol. 1, no. 2. (December): e82.
  • 2005. The management of pediatric systemic lupus erythematosus.  Nature clinical practice. Rheumatology.. Vol. 1, no. 2. (December 1).
  • 2005. A man with chest pain and glomerulonephritis.  LANCET. Vol. 365, no. 9476. (June 11).
  • Turner JW; Pien BC; Ardoin SA; Anderson AM; Shieh WJ; Zaki SR; Bhatnagar J; Guarner J; Howell DN; Woods CW. 2005. A Man with Chest Pain and Glomerulonephritis.  Lancet. Vol. 365, no. 9476. (June): e2062.
  • 2003. Infliximab to treat pediatric chronic inflammatory uveitis.
  • 1997. [Systemic lupus erythematosus].
  • 1986. Vasculitis.
  • 1948. POLYARTERITIS NODOSA.
  • Ardoin SP, Schanberg LE. The management of pediatric systemic lupus erythematosus.  Nature Clinical Practice.
  • Badhan S, Ardoin SP. Polyarteritis Nodosa. In Dean-Sabatini Atlas of Vascular Medicine.
  • Mascarenhas S, Ardoin SP. ANCA-associated Vasculitis. In Dean-Sabatini Atlas of Vascular Medicine.
  • Mascarenhas S, Ardoin SP. ANCA-associated Vasculitis. In Dean-Sabatini Atlas of Vascular Medicine.
  • Chira P, Ronis T, Ardoin SP, White P. Transitioning Youth with Rheumatic Conditions: Perspectives of Pediatric Rheumatology Providers in the United States and Canada.  J Rheumatol.
  • Ardoin SP, Schanberg LE. The management of pediatric systemic lupus erythematosus.  Nature Clinical Practice.
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000